This is an unofficial archive of PsychonautWiki as of 2025-08-08T03:33:20Z. Content on this page may be outdated, incomplete, or inaccurate. Please refer to the original page for the most up-to-date information.
1cP-LSD: Difference between revisions
>LockPicker m grammar |
>LockPicker legal status |
||
| Line 4: | Line 4: | ||
{{SummarySheet}} | {{SummarySheet}} | ||
{{SubstanceBox/1cP-LSD}} | {{SubstanceBox/1cP-LSD}} | ||
'''1-Cyclopropionyl-''d''-lysergic acid diethylamide''' (known as '''1cP-LSD''') is a novel semisynthetic [[Psychoactive class::psychedelic]] substance of the [[Chemical class::lysergamide]] class. It induces its psychedelic effects by acting on [[serotonin]] [[receptors]] in the brain.<ref name="Brandt2020">{{cite journal|title=Return of the lysergamides. Part VI: Analytical and behavioural characterization of 1‐cyclopropanoyl‐d‐lysergic acid diethylamide (1CP‐LSD)|first1=Simon D.|last1=Brandt|first2=Pierce V.|last2=Kavanagh|first3=Folker|last3=Westphal|first4=Alexander|last4=Stratford|first5=Anna U.|last5=Odland|first6=Adam K.|last6=Klein|first7=Geraldine|last7=Dowling|first8=Nicola M.|last8=Dempster|first9=Jason|last9=Wallach|first10=Torsten|last10=Passie|first11=Adam L.|last11=Halberstadt|date=March 16, 2020|doi=10.1002/dta.2789|volume=12|issue=6|journal=Drug Testing and Analysis|pages=812-826|eissn=1942-7611|issn=1942-7603|oclc=231680670}}</ref> 1cP-LSD is closely related to [[1P-LSD]] and [[LSD]]. It is reported to produce similar to identical effects. | '''1-Cyclopropionyl-''d''-lysergic acid diethylamide''' (known as '''1cP-LSD''') is a novel semisynthetic [[Psychoactive class::psychedelic]] substance of the [[Chemical class::lysergamide]] class. It induces its psychedelic effects by acting on [[serotonin]] [[receptors]] in the brain.<ref name="Brandt2020">{{cite journal|title=Return of the lysergamides. Part VI: Analytical and behavioural characterization of 1‐cyclopropanoyl‐d‐lysergic acid diethylamide (1CP‐LSD)|first1=Simon D.|last1=Brandt|first2=Pierce V.|last2=Kavanagh|first3=Folker|last3=Westphal|first4=Alexander|last4=Stratford|first5=Anna U.|last5=Odland|first6=Adam K.|last6=Klein|first7=Geraldine|last7=Dowling|first8=Nicola M.|last8=Dempster|first9=Jason|last9=Wallach|first10=Torsten|last10=Passie|first11=Adam L.|last11=Halberstadt|date=March 16, 2020|doi=10.1002/dta.2789|volume=12|issue=6|journal=Drug Testing and Analysis|pages=812-826|eissn=1942-7611|issn=1942-7603|oclc=231680670|pmid=32180350}}</ref> 1cP-LSD is closely related to [[1P-LSD]] and [[LSD]]. It is reported to produce similar to identical effects. | ||
Little is known about the pharmacology. Incubation of 1CP‐LSD with human serum led to the formation of LSD, indicating that it may act as a [[prodrug]] for LSD.<ref name="Brandt2020"></ref> | Little is known about the pharmacology. Incubation of 1CP‐LSD with human serum led to the formation of LSD, indicating that it may act as a [[prodrug]] for LSD.<ref name="Brandt2020"></ref> | ||
| Line 173: | Line 173: | ||
==Legal status== | ==Legal status== | ||
{{LegalStub}} | {{LegalStub}} | ||
*'''Germany''': 1cP-LSD is not a controlled substance under the BtMG (''Narcotics Act'')<ref>{{cite web|title=Betäubungsmittelgesetz (BtMG)|trans-title=Narcotics Act (BtMG)|url=http://www.gesetze-im-internet.de/btmg_1981/BtMG.pdf|publisher=Bundesamt für Justiz [Federal Office of Justice]|language=de|access-date=July 14, 2020|date=July 28, 1981}}</ref> or the NpSG (''New Psychoactive Substances Act'').<ref>{{cite web|title=Neue-psychoaktive-Stoffe-Gesetz (NpSG)|trans-title=New Psychoactive Substances Act (NpSG)|url=https://www.gesetze-im-internet.de/npsg/NpSG.pdf|date=November 21, 2016|access-date=July 14, 2020|publisher=Bundesamt für Justiz [Federal Office of Justice]|language=de}}</ref> It is legal, as long as it is not sold for human consumption, according to §2 AMG.<ref>{{cite web|title=§2 Arzneimittelgesetz (AMG)|trans-title=§2 Pharmaceutical Act (AMG)|url=https://www.gesetze-im-internet.de/amg_1976/__2.html|language=de|access-date=July 14, 2020|language=de|publisher=Bundesamt für Justiz [Federal Office of Justice]}}</ref> | |||
*'''Sweden''': Sweden's public health agency suggested classifying 1cP-LSD as a dangerous substance on December 18, 2019.<ref>{{cite web|url=https://www.folkhalsomyndigheten.se/nyheter-och-press/nyhetsarkiv/2019/december/tjugotre-amnen-foreslas-klassas-som-narkotika-eller-halsofarlig-vara/|title=Tjugotre ämnen föreslås klassas som narkotika eller hälsofarlig vara | trans-title = Twenty-three substances are proposed to be classified as drugs or dangerous goods |publisher=Folkhälsomyndigheten [Public Health Agency of Sweden]|language=sv|date=December 18, 2019|access-date=July 14, 2020}}</ref> | |||
*'''United Kingdom''': 1cP-LSD is illegal to produce, supply, or import under the Psychoactive Substance Act, which came into effect on May 26, 2016.<ref>{{cite web|title=Psychoactive Substances Act 2016|publisher=legislation.gov.uk|url=http://www.legislation.gov.uk/ukpga/2016/2/contents/enacted|access-date=July 14, 2020}}</ref> | |||
==See also== | ==See also== | ||